These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24882783)

  • 21. Magnetic resonance imaging-conditional devices: Luxury or real clinical need?
    Mavrogeni SI; Poulos G; Kolovou G; Theodorakis G
    Hellenic J Cardiol; 2017; 58(4):256-260. PubMed ID: 28089649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. German Roentgen Society Statement on MR Imaging of Patients with Cardiac Pacemakers.
    Sommer T; Luechinger R; Barkhausen J; Gutberlet M; Quick HH; Fischbach K;
    Rofo; 2015 Sep; 187(9):777-87. PubMed ID: 26308534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac perforation and lead dislodgement after implantation of a MR-conditional pacing lead: a single-center experience.
    Elmouchi DA; Rosema S; Vanoosterhout SM; Khan M; Davis AT; Gauri AJ; Finta B; Woelfel AK; Chalfoun NT
    Pacing Clin Electrophysiol; 2014 Jan; 37(1):4-10. PubMed ID: 24215291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla.
    Gimbel JR
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):795-801. PubMed ID: 18684275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers.
    Muehling OM; Wakili R; Greif M; von Ziegler F; Morhard D; Brueckmann H; Becker A
    J Cardiovasc Magn Reson; 2014 Jun; 16(1):39. PubMed ID: 24903354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla.
    Naehle CP; Zeijlemaker V; Thomas D; Meyer C; Strach K; Fimmers R; Schild H; Sommer T
    Pacing Clin Electrophysiol; 2009 Dec; 32(12):1526-35. PubMed ID: 19793358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac pacemaker: in vitro assessment at 1.5 T.
    Shellock FG; Fieno DS; Thomson LJ; Talavage TM; Berman DS
    Am Heart J; 2006 Feb; 151(2):436-43. PubMed ID: 16442911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocenter feasibility study of the MRI compatibility of the Evia pacemaker in combination with Safio S pacemaker lead.
    Wollmann CG; Steiner E; Vock P; Ndikung B; Mayr H
    J Cardiovasc Magn Reson; 2012 Sep; 14(1):67. PubMed ID: 23009683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Safety of magnetic resonance imaging in patients with pacemaker and implantable defibrillator].
    Al-Sabagh KH; Christensen BE; Thøgersen AM; Petersen HH; Videbaek R; Pehrson S; Chen X; Thomsen C; Svendsen JH
    Ugeskr Laeger; 2010 Jun; 172(23):1740-4. PubMed ID: 20534201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of magnetic resonance imaging in patients with permanent pacemakers: a collaborative clinical approach.
    Boilson BA; Wokhlu A; Acker NG; Felmlee JP; Watson RE; Julsrud PR; Friedman PA; Cha YM; Rea RF; Hayes DL; Shen WK
    J Interv Card Electrophysiol; 2012 Jan; 33(1):59-67. PubMed ID: 21938517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla.
    Martin ET; Coman JA; Shellock FG; Pulling CC; Fair R; Jenkins K
    J Am Coll Cardiol; 2004 Apr; 43(7):1315-24. PubMed ID: 15063447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of pacemaker and lead system for safe scanning at 1.5 Tesla.
    Gimbel JR; Bello D; Schmitt M; Merkely B; Schwitter J; Hayes DL; Sommer T; Schloss EJ; Chang Y; Willey S; Kanal E;
    Heart Rhythm; 2013 May; 10(5):685-91. PubMed ID: 23333721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Magnetic resonance imaging of the brain in patients with cardiac pacemakers. Experimental and clinical investigations at 1.5 Tesla].
    Schmiedel A; Hackenbroch M; Yang A; Nähle CP; Skowasch D; Meyer C; Schimpf R; Schild H; Sommer T
    Rofo; 2005 May; 177(5):731-44. PubMed ID: 15871088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices.
    Nazarian S; Hansford R; Roguin A; Goldsher D; Zviman MM; Lardo AC; Caffo BS; Frick KD; Kraut MA; Kamel IR; Calkins H; Berger RD; Bluemke DA; Halperin HR
    Ann Intern Med; 2011 Oct; 155(7):415-24. PubMed ID: 21969340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI Mode Programming for Safe Magnetic Resonance Imaging in Patients With a Magnetic Resonance Conditional Cardiac Device.
    Nakai T; Kurokawa S; Ikeya Y; Iso K; Takahashi K; Sasaki N; Ashino S; Okubo K; Okumura Y; Kunimoto S; Watanabe I; Hirayama A
    Int Heart J; 2016; 57(2):173-6. PubMed ID: 26973263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.
    Naehle CP; Strach K; Thomas D; Meyer C; Linhart M; Bitaraf S; Litt H; Schwab JO; Schild H; Sommer T
    J Am Coll Cardiol; 2009 Aug; 54(6):549-55. PubMed ID: 19643318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices.
    Roguin A; Schwitter J; Vahlhaus C; Lombardi M; Brugada J; Vardas P; Auricchio A; Priori S; Sommer T
    Europace; 2008 Mar; 10(3):336-46. PubMed ID: 18308754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current clinical issues for MRI scanning of pacemaker and defibrillator patients.
    Kalin R; Stanton MS
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):326-8. PubMed ID: 15826268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety evaluation of a leadless transcatheter pacemaker for magnetic resonance imaging use.
    Soejima K; Edmonson J; Ellingson ML; Herberg B; Wiklund C; Zhao J
    Heart Rhythm; 2016 Oct; 13(10):2056-63. PubMed ID: 27374239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices.
    Bhuva AN; Moralee R; Brunker T; Lascelles K; Cash L; Patel KP; Lowe M; Sekhri N; Alpendurada F; Pennell DJ; Schilling R; Lambiase PD; Chow A; Moon JC; Litt H; Baksi AJ; Manisty CH
    Eur Heart J; 2022 Jul; 43(26):2469-2478. PubMed ID: 34435642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.